200 related articles for article (PubMed ID: 25159681)
21. Prognostic Significance of the Location of Lymph Node Metastases in Patients With Adenocarcinoma of the Distal Esophagus or Gastroesophageal Junction.
Anderegg MC; Lagarde SM; Jagadesham VP; Gisbertz SS; Immanuel A; Meijer SL; Hulshof MC; Bergman JJ; van Laarhoven HW; Griffin SM; van Berge Henegouwen MI
Ann Surg; 2016 Nov; 264(5):847-853. PubMed ID: 27429034
[TBL] [Abstract][Full Text] [Related]
22. The prognostic significance of tumor ploidy and pathology in adenocarcinoma of the esophagogastric junction.
Schneeberger AL; Finley RJ; Troster M; Lohmann R; Keeney M; Inculet RI
Cancer; 1990 Mar; 65(5):1206-10. PubMed ID: 2302668
[TBL] [Abstract][Full Text] [Related]
23. Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome.
Barbour AP; Rizk NP; Gonen M; Tang L; Bains MS; Rusch VW; Coit DG; Brennan MF
Ann Surg Oncol; 2007 Feb; 14(2):306-16. PubMed ID: 17091329
[TBL] [Abstract][Full Text] [Related]
24. Impact of lower mediastinal lymphadenectomy for the treatment of esophagogastric junction carcinoma.
Hosoda K; Yamashita K; Katada N; Moriya H; Mieno H; Sakuramoto S; Kikuchi S; Watanabe M
Anticancer Res; 2015 Jan; 35(1):445-56. PubMed ID: 25550586
[TBL] [Abstract][Full Text] [Related]
25. Comparison between site N-category and number N-category for nodal staging in carcinoma of the gastroesophageal junction: our experience and literature review.
Aurello P; D'Angelo F; Nigri G; Bellagamba R; Cicchini C; Ruzzetti R; Ramacciato G
Am Surg; 2006 Feb; 72(2):118-23. PubMed ID: 16536239
[TBL] [Abstract][Full Text] [Related]
26. Increased Rac1 activity and Pak1 overexpression are associated with lymphovascular invasion and lymph node metastasis of upper urinary tract cancer.
Kamai T; Shirataki H; Nakanishi K; Furuya N; Kambara T; Abe H; Oyama T; Yoshida K
BMC Cancer; 2010 Apr; 10():164. PubMed ID: 20426825
[TBL] [Abstract][Full Text] [Related]
27. Comparison of prognostic compatibility between seventh AJCC/TNM of the esophagus and 14th JCGC staging systems in Siewert type II adenocarcinoma.
Kawaguchi T; Komatsu S; Ichikawa D; Kubota T; Okamoto K; Shiozaki A; Fujiwara H; Konishi H; Morimura R; Murayama Y; Kuriu Y; Ikoma H; Nakanishi M; Sakakura C; Otsuji E
Anticancer Res; 2013 Aug; 33(8):3461-5. PubMed ID: 23898120
[TBL] [Abstract][Full Text] [Related]
28. Identification of the distinct genomic features in gastroesophageal junction adenocarcinoma and its Siewert subtypes.
Geng Q; Lao J; Zuo X; Chen S; Bei JX; Xu D
J Pathol; 2020 Nov; 252(3):263-273. PubMed ID: 32715475
[TBL] [Abstract][Full Text] [Related]
29. Lymph node ratio-based staging system as an alternative to the current TNM staging system to assess outcome in adenocarcinoma of the esophagogastric junction after surgical resection.
Zhang H; Shang X; Chen C; Gao Y; Xiao X; Tang P; Duan X; Yang M; Jiang H; Yu Z
Oncotarget; 2016 Nov; 7(45):74337-74349. PubMed ID: 27517157
[TBL] [Abstract][Full Text] [Related]
30. Correlations of P21-activated kinase 1 expression to clinicopathological features of gastric carcinoma and patients' prognosis.
Wang JX; Zhou YN; Zou SJ; Ren TW; Zhang ZY
Chin J Cancer; 2010 Jul; 29(7):649-54. PubMed ID: 20591216
[TBL] [Abstract][Full Text] [Related]
31. Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC--A Randomized Phase III Trial.
Hecht JR; Bang YJ; Qin SK; Chung HC; Xu JM; Park JO; Jeziorski K; Shparyk Y; Hoff PM; Sobrero A; Salman P; Li J; Protsenko SA; Wainberg ZA; Buyse M; Afenjar K; Houé V; Garcia A; Kaneko T; Huang Y; Khan-Wasti S; Santillana S; Press MF; Slamon D
J Clin Oncol; 2016 Feb; 34(5):443-51. PubMed ID: 26628478
[TBL] [Abstract][Full Text] [Related]
32. Immune Infiltration Subtypes Characterization and Identification of Prognosis-Related lncRNAs in Adenocarcinoma of the Esophagogastric Junction.
Hu X; Wu L; Liu B; Chen K
Front Immunol; 2021; 12():651056. PubMed ID: 34122409
[TBL] [Abstract][Full Text] [Related]
33. [Adenocarcinoma of the esophagogastric junction: association with Barrett esophagus and gastroesophageal reflux--surgical results in 122 patients].
Schumpelick V; Dreuw B; Ophoff K; Fass J
Leber Magen Darm; 1996 Mar; 26(2):75-6, 79-80, 83-6. PubMed ID: 8684248
[TBL] [Abstract][Full Text] [Related]
34. Lymphatic spread and microinvolvement in adenocarcinoma of the esophago-gastric junction.
Schurr PG; Yekebas EF; Kaifi JT; Lasch S; Strate T; Kutup A; Cataldegirmen G; Bubenheim M; Pantel K; Izbicki JR
J Surg Oncol; 2006 Sep; 94(4):307-15. PubMed ID: 16917878
[TBL] [Abstract][Full Text] [Related]
35. Topographical distribution of lymph node metastasis in adenocarcinoma of the gastroesophageal junction.
Mönig SP; Baldus SE; Zirbes TK; Collet PH; Schröder W; Schneider PM; Dienes HP; Hölscher AH
Hepatogastroenterology; 2002; 49(44):419-22. PubMed ID: 11995464
[TBL] [Abstract][Full Text] [Related]
36. [Clinical and pathological prognostic factors for cancers of the esophagogastric junction].
Schmidt SC; Schlechtweg N; Veltzke-Schlieker W; Thuss-Patience P; Pratschke J; Neuhaus P; Schumacher G
Zentralbl Chir; 2009 Sep; 134(5):455-61. PubMed ID: 19757346
[TBL] [Abstract][Full Text] [Related]
37. Combination of preoperative platelet/lymphocyte and neutrophil/lymphocyte rates and tumor-related factors to predict lymph node metastasis in patients with gastric cancer.
Pang W; Lou N; Jin C; Hu C; Arvine C; Zhu G; Shen X
Eur J Gastroenterol Hepatol; 2016 May; 28(5):493-502. PubMed ID: 26854795
[TBL] [Abstract][Full Text] [Related]
38. Seventh tumor-node-metastasis staging of gastric cancer: Five-year follow-up.
Rausei S; Ruspi L; Galli F; Pappalardo V; Di Rocco G; Martignoni F; Frattini F; Rovera F; Boni L; Dionigi G
World J Gastroenterol; 2016 Sep; 22(34):7748-53. PubMed ID: 27678357
[TBL] [Abstract][Full Text] [Related]
39. Screening and clinical significance of lymph node metastasis-related genes within esophagogastric junction adenocarcinoma.
Han R; Chen G; Li M; Peng ZM; Xu L
Cancer Med; 2021 Aug; 10(15):5088-5100. PubMed ID: 34152098
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic approaches to gastroesophageal junction adenocarcinomas.
Blom RL; Bogush T; Brücher BL; Chang AC; Davydov M; Dudko E; Leong T; Polotsky B; Swanson PE; van Rossum PS; Ruurda JP; Sagaert X; Tjulandin S; Schraepen MC; Sosef MN; van Hillegersberg R
Ann N Y Acad Sci; 2014 Sep; 1325():197-210. PubMed ID: 25266026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
